Evaluation of IMVAMUNE Smallpox Vaccine With Respect to Safety and Optimization of Immune Responses by Different Vaccination Regimens in Vaccinia-Naive Adults.

Trial Profile

Evaluation of IMVAMUNE Smallpox Vaccine With Respect to Safety and Optimization of Immune Responses by Different Vaccination Regimens in Vaccinia-Naive Adults.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 15 Nov 2013

At a glance

  • Drugs Smallpox vaccine (Primary)
  • Indications Smallpox
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 09 May 2013 Results published in Vaccine.
    • 16 Mar 2010 Actual patient number (226) added as reported by ClinicalTrials.gov.
    • 20 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top